Tengjun Biotechnology Corp. Comprehensive Income
Tengjun Biotechnology Corp. reported Comprehensive Income of -$2.46 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-08-15
- Tengjun Biotechnology Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$2.46M, a 163.36% decline year-over-year.
- Tengjun Biotechnology Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was $484.25K, a 130.75% increase year-over-year.
- Tengjun Biotechnology Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was $4.01M.
- Tengjun Biotechnology Corp. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was $3.00M.
- Tengjun Biotechnology Corp. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $11.10M.
- Tengjun Biotechnology Corp. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$783.82K.
- Tengjun Biotechnology Corp. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$759.09K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | -$2.46M 10-Q · filed 2023-08-15 | -$1.97M 10-Q · filed 2023-08-15 | $2.04M derived: sum of 3 quarters · filed 2023-08-15 | $5.04M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2023-03-31 | $484.25K 10-Q · filed 2023-05-15 | $4.50M derived: sum of 2 quarters · filed 2023-05-15 | $7.49M derived: sum of 3 quarters · filed 2023-05-15 | $11.37M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2022-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $7.01M derived: sum of 2 quarters · filed 2023-04-17 | $10.89M derived: sum of 3 quarters · filed 2023-08-15 | $11.10M 10-K · filed 2023-04-17 | ||
| 2022-09-30 | $3.00M 10-Q · filed 2022-11-14 | $6.87M derived: sum of 2 quarters · filed 2023-08-15 | $7.08M 10-Q · filed 2022-11-14 | $6.81M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2022-06-30 | $3.88M 10-Q · filed 2023-08-15 | -$3.07M 10-Q · filed 2022-08-15 | $4.09M 10-Q · filed 2023-08-15 | -$2.86M 10-Q · filed 2022-08-15 | $3.82M derived: sum of 3 quarters · filed 2023-08-15 | $3.70M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | $209.86K 10-Q · filed 2023-05-15 | -$61.50K derived: sum of 2 quarters · filed 2023-05-15 | -$172.48K derived: sum of 3 quarters · filed 2023-05-15 | -$414.45K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$271.36K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$382.34K derived: sum of 2 quarters · filed 2023-04-17 | -$624.31K derived: sum of 3 quarters · filed 2023-04-17 | -$783.82K 10-K · filed 2023-04-17 | ||
| 2021-09-30 | -$110.98K 10-Q · filed 2022-11-14 | -$352.95K derived: sum of 2 quarters · filed 2022-11-14 | -$512.45K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$241.97K 10-Q/A · filed 2022-09-16 | -$401.48K 10-Q/A · filed 2022-09-16 | ||||
| 2021-03-31 | -$159.50K 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | -$759.09K 10-K · filed 2022-03-31 |